Stockscreener 앱 받기
1.15
1.71%
-0.02
시간 외 거래:
1.15
전일 마감가:
$1.17
열려 있는:
$1.17
하루 거래량:
13,087
Relative Volume:
0.13
시가총액:
$11.93M
수익:
-
순이익/손실:
$-15.42M
주가수익비율:
-0.6534
EPS:
-1.76
순현금흐름:
$-13.41M
1주 성능:
-7.26%
1개월 성능:
-0.86%
6개월 성능:
-43.07%
1년 성능:
-54.00%
1일 변동 폭
$1.1401
$1.19
1주일 범위
$1.08
$1.25
52주 변동 폭
$1.03
$3.25
Indaptus Therapeutics Inc Stock (INDP) Company Profile
명칭
Indaptus Therapeutics Inc
전화
(646) 427-2727
주소
3 COLUMBUS CIRCLE, NEW YORK
Indaptus Therapeutics Inc 주식(INDP)의 최신 뉴스
Indaptus Therapeutics to Present at Two Upcoming Investor Conferences - The Manila Times
Indaptus Therapeutics partners with BeiGene for cancer study By Investing.com - Investing.com Canada
Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment - Morningstar
Indaptus Therapeutics partners with BeiGene for cancer study - Investing.com
Indaptus Therapeutics Announces Clinical Supply Agreement - GlobeNewswire
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations - The Manila Times
Indaptus Therapeutics, Inc. Enters into Clinical Supply Agreement with Beigene Switzerland GmbH - Marketscreener.com
Provident Bank's First-Time Home Buyer Survey Reveals That While Homeownership Continues to Be Challenging, Many Americans Are Finding Their Home in Less Than a Year - The Manila Times
Indaptus Therapeutics Initiates Unrestricted Enrollment of - GlobeNewswire
Indaptus Therapeutics (INDP) Price Target Increased by 25.00% to 10.20 - MSN
Indaptus Therapeutics Founder and Chief Scientific Officer - GlobeNewswire
Indaptus Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Short Interest in Indaptus Therapeutics, Inc. (NASDAQ:INDP) Increases By 140.5% - Defense World
Cybin (NYSEAMERICAN:CYBN) Shares Down 4.4% - Defense World
Japan Tobacco Inc. (OTCMKTS:JAPAY) Short Interest Update - Defense World
Sei Investments Co. Has $17.72 Million Position in Teradata Co. (NYSE:TDC) - Defense World
Indaptus Therapeutics (NASDAQ:INDP) Stock Price Down 9.2% - Defense World
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights - Marketscreener.com
Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term IART Shareholders to Contact the Firm - Business Wire
The Escalator: Imre, Kyverna Therapeutics, The Bloc and more - MM+M Online
StockNews.com Downgrades Independent Bank (NASDAQ:INDB) to Sell - Defense World
Integrated BioPharma (OTCMKTS:INBP) Trading Down 2.2% - Defense World
Indivior PLC REMINDER – INDV Stockholders Should Contact - GlobeNewswire
IBTX stock hits 52-week high at $60.77 amid robust growth - Investing.com
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit - PR Newswire
Northland Capmk Equities Analysts Cut Earnings Estimates for Indivior PLC (NASDAQ:INDV) - MarketBeat
Holdings of Intelligent Bio Solutions Inc (INBS) are aligned with the stars - SETE News
Upward Trajectory: Intelligent Bio Solutions Inc (INBS) Posts a Gaine, Closing at 2.48 - The Dwinnex
Imunon (NASDAQ:IMNN) Shares Up 5.6% - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Indivior PLC of Class Action Lawsuit and Upcoming DeadlinesINDV - PR Newswire
Financial Health Check: Examining Indivior Plc (INDV)’s Key Ratios - The Dwinnex
Class Action Lawsuit Against Indivior PLC (NASDAQ:INDV) - TipRanks
Ready to Jump After Recent Trade: Indivior Plc (INDV) - SETE News
Indivior PLC Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsINDV - PR Newswire
Intelligent Bio Solutions Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value - GlobeNewswire
Technical analysis of Intelligent Bio Solutions Inc (INBS) stock chart patterns - US Post News
Negative FDA AdCom vote on Ocaliva - The Pharma Letter
The Gross Law Firm Reminds Indivior Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 1, 2024INDV - PR Newswire
Piper Sandler Reaffirms “Overweight” Rating for Indivior (NASDAQ:INDV) - Defense World
INDV SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Indivior PLC Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Indivior PLC (NASDAQ:INDV) Shares Sold by Royal London Asset Management Ltd. - MarketBeat
INVESTOR ALERT: DiCello Levitt LLP Shareholder Class Action - GlobeNewswire
Indivior's (INDV) Overweight Rating Reiterated at Piper Sandler - MarketBeat
Intl Paper Co stock hits 52-week high at $49.25 amid market rally By Investing.com - Investing.com South Africa
In the Green: Indivior Plc (INDV) Closes at 9.62, Up/Down 0.42 from Previous Day - The Dwinnex
INmune Bio stock dips on $13M securities offering - MSN
Indaptus Therapeutics Reports Encouraging New Safety Data - GlobeNewswire
INDP stock touches 52-week low at $1.55 amid market challenges - Investing.com Canada
Indaptus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Intec Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020 - Marketscreener.com
Indaptus Therapeutics Inc (INDP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):